Ritodrine
Ritodrine is a pharmaceutical drug with 3 clinical trials. Historical success rate of 100.0%.
Registry-listed formulations
Ritodrine · chembl:CHEMBL83063
Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.
1 source entries across 1 studies. This list may not include all unresolved or historical entries.
- Ritodrine Oral TabletRegistry intervention
Molecular identity unconfirmed
View study and source
Success Metrics
Based on 2 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
0
Mid Stage
2
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
2 of 2 finished
0.0%
0 ended early
0
trials recruiting
3
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Comparative Study Between Nifedipine and Ritodrine as Maintenance Tocolytic Therapy in Preterm Labor
Tocolysis in Prevention of Preterm Labor
Influence of Tocolytical Medications on Hemodynamics (Central and Peripheral) and Vascular Function in a Pilot Study to Determine the Design of the Final Study and the Final Study Itself
Clinical Trials (3)
Comparative Study Between Nifedipine and Ritodrine as Maintenance Tocolytic Therapy in Preterm Labor
Tocolysis in Prevention of Preterm Labor
Influence of Tocolytical Medications on Hemodynamics (Central and Peripheral) and Vascular Function in a Pilot Study to Determine the Design of the Final Study and the Final Study Itself
All 3 trials loaded
Drug Details
- Intervention Type
- Drug
- Molecule Type
- Small molecule
- Total Trials
- 3